Copyright
©The Author(s) 2022.
World J Clin Oncol. Mar 24, 2022; 13(3): 159-167
Published online Mar 24, 2022. doi: 10.5306/wjco.v13.i3.159
Published online Mar 24, 2022. doi: 10.5306/wjco.v13.i3.159
Gastrectomy | Esophagectomy |
+ Only abdominal approach, avoiding thoracotomy/thoracoscopic associated morbidity | + Better proximal and circumferential resection margins |
+ Adequate abdominal lymph node dissection | + Extensive mediastinal lymph node dissection |
+ No GERD/No PPI | + Preservation of ¾ of stomach |
- Inadequate mediastinal lymph node dissection | - Abdominal and thoracic approach |
- Shorter proximal margins | - Hiatal herniation risk |
- Vitamin B12 malabsorption | - Gastroesophageal reflux (necessity of PPI) |
- Dumping | - Pylorospasm |
- Citation: Schlottmann F, Casas MA, Molena D. Evidence-based approach to the treatment of esophagogastric junction tumors. World J Clin Oncol 2022; 13(3): 159-167
- URL: https://www.wjgnet.com/2218-4333/full/v13/i3/159.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i3.159